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Bacterial toxin-antitoxin (TA) systems typically consist of a small, labile antitoxin that inactivates a specific
longer-lived toxin. In Escherichia coli, such antitoxins are proteolytically regulated by the ATP-dependent
proteases Lon and ClpP. Under normal conditions, antitoxin synthesis is sufficient to replace this loss from
proteolysis, and the bacterium remains protected from the toxin. However, if TA production is interrupted,
antitoxin levels decrease, and the cognate toxin is free to inhibit the specific cellular component, such as
mRNA, DnaB, or gyrase. To date, antitoxin degradation has been studied only in E. coli, so it remains unclear
whether similar mechanisms of regulation exist in other organisms. To address this, we followed antitoxin
levels over time for the three known TA systems of the major human pathogen Staphylococcus aureus, mazEF,
axe1-txe1, and axe2-txe2. We observed that the antitoxins of these systems, MazEsa, Axe1, and Axe2, respectively,
were all degraded rapidly (half-life [t1/2], 18 min) at rates notably higher than those of their E. coli
counterparts, such as MazE (t1/2, 30 to 60 min). Furthermore, when S. aureus strains deficient for various
proteolytic systems were examined for changes in the half-lives of these antitoxins, only strains with clpC or
clpP deletions showed increased stability of the molecules. From these studies, we concluded that ClpPC serves
as the functional unit for the degradation of all known antitoxins in S. aureus.
Staphylococcus aureus is a versatile human pathogen responsi-
ble for an increasing number of hospital- and community-ac-
quired infections (33, 41) ranging from superficial skin lesions to
life-threatening sepsis, endocarditis, and toxic shock (29). S. au-
reus’ capacity to cause illness is enhanced by its robust stress
response, which allows it to endure adverse conditions, such as
heat, antibiotics, and nutritional deprivation. This is mediated in
part by transcriptional regulators, like CtsR (11), CodY (31), and
the alternative sigma factor B (24), that allow the bacteria to
rapidly adjust to challenging environments.
The roles of chromosomal toxin-antitoxin (TA) modules in
environmental and antibiotic stress response have been docu-
mented for a variety of organisms, especially Escherichia coli,
but only recently have they been investigated in S. aureus (12,
18, 43). These systems typically consist of a pair of cotrans-
cribed stress-inducible genes (19) that encode a stable toxin
and a more labile antitoxin. Depletion of the antitoxin allows
activation of its cognate toxin, which is then free to interfere
with a specific cellular target, such as mRNA, DNA gyrase, or
DNA helicase. Depending on the species and the TA system,
this activation results in a variety of phenotypes, but those
related to growth, stress response, starvation, and persistence
are often seen (12, 19, 30). For example, Streptococcus mutans
devoid of its TA systems is more susceptible to changes in
nutrient availability and pH than its counterpart wild-type
strains (26). Furthermore, TA systems are absent in obligate
intracellular organisms (37), suggesting that they are not nec-
essary for growth in stable intracellular environments.
Previous reports have demonstrated that at least three TA
systems exist in S. aureus (12, 43), annotated as mazEF (SAS0167/
SA1873), axe1-txe1 (SA2196-5), and axe2-txe2 (SA2246-5). Al-
though mazEF was named for its similarity to mazEF in E. coli,
its transcriptional regulation (12) and ribonucleic target se-
quences are considerably different from those of E. coli mazEF
(17). The axe1-txe1 and axe2-txe2 TA systems have significant
homology to one another (48% amino acid similarity for both
antitoxins and toxins), as well as to both the relBE (37) and
yefM-yoeB (6) TA systems in E. coli. Like the mazEF system,
both of the systems in S. aureus show transcriptional activation
in response to select antibiotics (12) and have specific endori-
bonucleic activities (43).
As a functional family, antitoxins can be either small RNAs
(class I) or proteins (class II) (20) that specifically bind to a
cognate toxin and inhibit its enzymatic activity; in the case of S.
aureus, all three antitoxins appear to belong to the latter group
(12, 43). Class II antitoxins are often strongly acidic and are
thought to be largely unstructured (28), attributes that facili-
tate the conformational changes necessary to enable the tight
binding needed to repress their positively charged toxins. The
unfolded nature of these antitoxins is also thought to contrib-
ute to their degradation (34), as protein unfolding is an im-
portant first step in the delivery and processing of the target
protein by ATP-dependent proteases.
While the TA systems of a variety of bacteria have been
shown to respond transcriptionally to environmental and anti-
biotic stresses (4, 12), little is known about the proteolytic
regulation of TA systems in species other than E. coli (19). In
that organism, two of the four proteolytic systems (Lon, ClpP,
FtsH, and HslVU [ClpQY]) are involved in antitoxin degrada-
tion: Lon breaks down the antitoxins RelB (9), MazE (10),
ParD (39), and CcdA (42), while the ClpP protease degrades
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MazE (1), PhD (25), and YefM (6). On its own, ClpP can
degrade only small peptides, but it employs an Hsp100/Clp
ATPase chaperone (1, 25) to unfold and translocate proteins
with specific amino acid signal sequences (e.g., C-terminal AA
and LCN motifs) (8, 36, 38) into its proteolytic core. In E. coli,
the ClpA and ClpX chaperones have both been shown to be
critical to this ClpP-mediated antitoxin degradation, but their
counterparts in S. aureus are less clear. S. aureus has a single
homologue of E. coli ClpX, but it also possesses several chap-
erones that have high similarity to ClpA (ClpB [59%], ClpC
[61%], and ClpL [61%]). Among these, only ClpC and ClpX
are thought to contain ClpP recognition sequences (14), sug-
gesting that ClpB and ClpL might not directly bind ClpP (al-
though that may not be a requirement to function as a ClpP
chaperone). In terms of function in S. aureus, ClpC appears to
mediate resistance to oxidative stress, enhance growth recov-
ery from the stationary and poststationary phases, and contrib-
ute to biofilm formation (5). ClpX has a role in osmoprotection
and, interestingly, also controls aspects of virulence gene reg-
ulation through an unidentified regulator of the agr system
(15). Less is known of the two other chaperones, ClpB and
ClpL, although roles in thermotolerance have been suggested
(14).
While neither of the other two ATP-dependent proteases in
E. coli, FtsH and HslVU, has been shown to be involved in
antitoxin degradation, S. aureus homologues of these proteases
conceivably could compensate for the lack of Lon. Strains
lacking FtsH have defects in osmotic and heat shock tolerance,
general cell growth, and starvation (27), phenotypes associated
with TA systems. Little is known of HslVU’s cellular function
in S. aureus other than that it has a limited role in stress
survival (16).
We report here that the antitoxins MazEsa, Axe1, and Axe2
from the three known TA systems in S. aureus are each rapidly
degraded in vivo, with half-lives (t1/2) of approximately 18 min,
rates that are faster than those of their E. coli counterparts.
Examination of the genetic components involved in S. aureus
antitoxin degradation revealed that strains lacking clpP showed
greatly decreased degradation rates for all three antitoxins,
while the rates were unchanged in ftsH- and hslV-deficient
strains. The chaperone ClpC was also shown to be the only
ATPase chaperone necessary for antitoxin breakdown. This
indicated that while S. aureus uses ClpP to degrade its antitox-
ins in a manner similar to that of E. coli, S. aureus TA regu-
lation is distinct from that of E. coli in that it employs the
Gram-positive-specific stress response chaperone ClpC (5, 14)
to facilitate antitoxin breakdown.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth media. Table 1 contains a list of
bacterial strains and plasmids used for this study. E. coli was grown in Luria-
Bertani (LB) broth or on plates containing LB agar, and S. aureus was grown in
trypticase soy broth (TSB) or agar (TSA). Competent S. aureus bacteria were
prepared in B2 medium as described previously (40). Antibiotics were used at the
following concentrations: erythromycin, 2.5 g/ml; ampicillin, 50 g/ml; chlor-
amphenicol, 10 g/ml; and rifampin, 200 g/ml. Xylose induction was performed
using 0.1% (vol/vol) xylose.
DNA manipulations. E. coli plasmid purification was performed using Qiagen
miniprep kits (Qiagen) according to the manufacturer’s instructions, while plas-
mid isolation from S. aureus was performed as described previously (40). Trans-
formations of S. aureus by plasmids were done via electroporation, using the
heavily mutagenized RN4220 as an intermediate between E. coli and relevant S.
aureus strains (40). The sequences of the primers used (IDT Technologies) are
available upon request.
Expression vector creation. To facilitate their detection in cell lysates, the
MazEsa, Axe1, and Axe2 antitoxins were epitope tagged with either N- or C-
terminal Myc (EQKLISEEDL) or hemagglutinin (HA) (YPYDVPDYA) tags
codon optimized for S. aureus. These tag sequences were joined to the antitoxin
genes by PCR amplification from the SH1000 chromosome, along with an up-
stream EcoRI site, a sarA ribosome-binding site, and a downstream XbaI site.
The products were digested using EcoRI and XbaI, ligated into a similarly
digested pEPSA5 vector, and used to transform competent E. coli XL1-Blue.
Successful transformants were verified by restriction digestion and DNA se-
quencing.
Construction of clp knockouts. The S. aureus genome contains genes for five
Clp ATPases (clpB, clpC, clpL, clpX, and clpY) and three ATP-dependent pep-
tidases (hslV [clpQ], clpP, and ftsH) (14, 27). Deletion of the first six of these
genes was performed in the SH1000 background using the temperature-sensitive
allelic replacement plasmid pMAD (3) to create clean, markerless deletions of
individual clp genes. Verification of theses deletions was performed by colony
PCR and chromosomal sequencing. For the clpP mutant in the SH1000 back-
ground, we repaired the 11-bp deletion in rsbU in the clpP mutant of 8325-4
TABLE 1. Strains and plasmids used in this study
Strain or
plasmid Description Reference or source
E. coli
XL1-Blue General cloning strain Agilent Technologies
S. aureus
8325-4 General laboratory strain; rsbU
mutant
35
RN4220 Heavily mutagenized NCTC8325-4 23
SH1000 8325-4 with a repaired rsbU gene 21
SaclpP 8325-4 with a clpP deletion 15
JM27 SH1000 ftsH::tet Tetr 27
ALC4976 SH1000 clean selectionless
deletion of clpB
This work
ALC4977 SH1000 clean selectionless
deletion of clpC
This work
ALC4978 SH1000 clean selectionless
deletion of clpL
This work
ALC4979 SH1000 clean selectionless
deletion of clpQ
This work
ALC4980 SH1000 clean selectionless
deletion of clpX
This work
ALC4981 SH1000 clean selectionless
deletion of clpY
This work
ALC5105 SaclpP with a repaired rsbU gene This work
ALC6490 SH1000 clpC complement This work
ALC6491 SH1000 clpP complement This work
Plasmids
pMAD E. coli/S. aureus shuttle plasmid
with the ori pE194ts; bgaB Ampr
Ermr
3
pCR2.1 E. coli PCR cloning vector Invitrogen
pEPSA5 Xylose-inducible shuttle vector;
Ampr Cmr
13
pALC4384 pMAD::clpY This work
pALC4404 pMAD::clpB This work
pALC4440 pMAD::clpQ This work
pALC4506 pMAD::clpC This work
pALC4507 pMAD::clpL This work
pALC4508 pMAD::clpX This work
pALC4946 pMAD::rsbU complement This work
pALC4077 pEPSA5::mazE This work
pALC6188 pEPSA5::mazEC-myc with a
C-terminal Myc tag
This work
pALC6486 pEPSA5::axe1N-myc with a
N-terminal Myc tag
This work
pALC6489 pEPSA5::axe2C-myc with a
C-terminal Myc tag
This work
pALC6682 pEPSA5::axe2C-HA with a
C-terminal HA tag
This work
pALC6492 pMAD::clpC complement This work
pALC6493 pMAD::clpP complement This work
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using a similar pMAD replacement strategy. Since the small size of this replace-
ment made the identification of a successful rsbU repair impractical by colony
PCR, enhanced pigmentation in putative rsbU strains was used for our initial
selection (24), followed by chromosomal sequencing of pigment-positive strains
for an intact rsbU gene. The SH1000 ftsH::tetM strain was a kind gift from S.
Foster (27).
Protein lysate preparation. To prepare protein lysates of SH1000 strains,
overnight cultures of S. aureus were diluted 1/100 in 100 ml of TSB and grown
with shaking at 250 rpm at 37°C (flask/medium ratio, 2.5:1). For those strains
overexpressing antitoxins from the pEPSA5 plasmid, 10 g/ml chloramphenicol
and 0.1% xylose were also added during the initial inoculation. At an A650 of 1.1,
200 g/ml rifampin was added to inhibit transcription (2), whereupon a 10-ml
aliquot was immediately withdrawn. Similar samples were taken every 15 min
thereafter. The cells were pelleted by centrifugation at 1°C, flash-frozen in liquid
nitrogen, and stored at 80°C. Once cells at all time points were collected, the
cells were thawed on wet ice and washed twice with ice-cold sample buffer (50
mM Tris-HCl, pH 7.6, 50 mM EDTA). The cells were then resuspended in 300
l of sample buffer, and 100 l of 0.1-mm silica/glass beads was added and then
mechanically disrupted in a Mini-beadbeater 8 at its maximum setting for two
1-min pulses punctuated by a 1-min rest on ice. The lysates were centrifuged at
20,000  g for 15 min at 1°C, and then aprotinin (1 g/ml), leupeptin (1 g/ml),
and phenylmethylsulfonyl fluoride (PMSF) (300 M) were added to the clarified
supernatants, and their protein concentrations were determined by Bradford
assay on a FL600 microplate reader (Biotek Instruments).
Western blot analysis. Twenty-five micrograms of lysate from the S. aureus
strains described above were separated by SDS-PAGE, transferred to polyvinyli-
dene difluoride (PVDF) membranes, and blocked overnight in Tris-buffered
saline (150 mM NaCl, 10 mM Tris, pH 8.0) with 0.1% (vol/vol) Tween 20
(TBS-T) and 5% dried milk. The membranes were then incubated with either
mouse anti-HA (-HA) (Cell Signaling), -Myc (Cell Signaling), -SarA (32),
-B (7), -MazFsa (17), or -MazEsa (17) antibodies in TBS-T for 2 h; washed
three times with TBS-T for 5 min each time; treated with horseradish peroxidase-
conjugated goat -mouse secondary antibody (Jackson ImmunoResearch) for 30
min; and washed again with TBS-T three times for 5 min each time. The
membranes were then covered with enhanced chemiluminescence (ECL) re-
agent (GE Healthcare) and exposed to film. Scanned images from nonsaturated
exposed film were then analyzed densitometrically using ImageJ, and the half-
lives were calculated using Prism 5 (Graphpad).
RESULTS
Evaluation of protein stability in S. aureus following tran-
scriptional inhibition. MazE degradation in E. coli was first
shown by comparing time points of lysates of 35S-labeled cells
grown during heat shock at 42°C, a condition that represses
MazE production (1). A more specific approach was used in
our studies, in which antitoxin levels were determined by West-
ern blotting, a method similar to that used by Christensen et al.
for RelB (9). To more easily expose the changes in antitoxin
levels over time, rifampin was added to cultures at a level
sufficient to stall RNA polymerase (200 g/ml) and block any
further transcription of TA mRNA (2). The use of a transcrip-
tional inhibitor like rifampin was desirable, because antibiotics
such as macrolides and tetracyclines that block translation also
have the undesirable effect of upregulating TA transcription in
S. aureus (12). However, to provide evidence that this treat-
ment did not alter protein levels in S. aureus in general, equiv-
alent amounts of lysates from strain SH1000 were separated
using SDS-PAGE and either Coomassie stained or Western
blotted using -SarA or -B antibodies. As seen in Fig. 1A,
rifampin treatment produced no gross changes in protein over
the course of treatment, and both B (Fig. 1B) and SarA (Fig.
1C) levels remained steady. This indicated that using rifampin
to transcriptionally stall S. aureus did not lead to significant
changes in the general turnover of cellular proteins.
MazEsa is rapidly degraded in S. aureus, while MazFsa is
stable. As antitoxin degradation is one of the key aspects of E.
coli TA regulation, we examined whether the S. aureus MazEsa
antitoxin was regulated in a similar manner. Western blots of
lysates made from transcriptionally stalled SH1000 cells over-
expressing MazEsa were probed with -MazEsa antibodies and
showed that the MazEsa levels rapidly decreased over time
after rifampin treatment to the point where the protein was
nearly undetectable after 30 min (Fig. 1D). Densitometry of
this progression indicated MazEsa has an in vivo half-life of
between 18 and 20 min, a rate faster than that reported for
MazE of E. coli (t1/2 	 30 min) (1). To determine if the S.
aureus MazFsa toxin was more stable than its cognate antitoxin,
MazFsa levels were tracked by immunoblotting rifampin-
treated SH1000 cell lysates using -MazFsa antibodies. As
shown in Fig. 1E, in contrast to the antitoxin MazEsa, MazFsa
levels remained relatively constant after transcriptional inhibi-
tion. This indicated that the S. aureus mazEF TA system was
posttranslationally regulated in a manner similar to that of its
homologue in E. coli.
Axe1 and Axe2 are degraded rapidly in vivo. We next exam-
ined whether the other two known antitoxins of S. aureus
exhibited degradation patterns similar to that of MazEsa. To
circumvent the issue that antisera to Axe1 and Axe2 were
unavailable, epitope-tagged versions of these antitoxins were
created to facilitate their detection. An in silico analysis sug-
gested that the addition of an HA or Myc tag to either termi-
nus caused no secondary-structure changes but also did not
reveal any known motifs involved in Clp-specific degradation
(e.g., LCN, FMLYPK, or AA motifs from Bacillus subtilis) (8,
36, 38). To guard against the possibility that such a tag could
affect the degradation of these proteins, separate constructs
were made that fused either HA or Myc epitope tags to the N
or C terminus of each antitoxin. As a related control, we
compared the degradation rate of untagged MazEsa to that of
Myc-tagged MazEsa and determined the half-life to be essen-
tially unchanged (20 minutes versus 18 min) (Fig. 1D and 2).
With this information, we proceeded to transcriptionally stall
SH1000 wild-type cells containing pEPSA5 plasmids capable
of overexpressing either axe1 or axe2 and withdrew samples
every 15 min. Western blot analysis of lysates made from these
cells revealed that the levels of both HA- and Myc-tagged
antitoxins of Axe2 dropped rapidly after rifampin treatment
(t1/2 	 20 min for Myc- and HA-tagged antitoxins) (Fig. 2 [also
see Fig. 6A] for the Myc tag; see Fig. 7A for the HA tag).
Similarly, Axe1 tagged with Myc (Fig. 2 [also see Fig. 5A]) or
HA (data not shown) displayed similar but rapid degradation
rates in strain SH1000. From these data, we concluded that the
Axe1 and Axe2 antitoxins were rapidly degraded in a fashion
similar to that of MazEsa in S. aureus.
clpP and clpC are required for antitoxin degradation in S.
aureus. To date, all proteolysis of E. coli antitoxins appears to
be through Lon or ClpP (19), with the latter deploying ClpA or
ClpX ATPase chaperones for this destruction. However, the
mechanism(s) of this degradation in S. aureus is less clear, as
not only does it lack a Lon homologue, it also contains several
Hsp100/Clp ATPases with similar levels of homology to ClpA
(ClpB [59% similarity], ClpC [61%], and ClpL [61%]). To
clarify the degradative mechanism, SH1000 strains lacking ei-
ther the three known ATP-dependent protease genes, ftsH,
clpP, and hslV (clpQ), or their chaperones, clpB, clpC, clpL,
clpX, and clpY (hslU), were made. These strains were then
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transformed with either pALC6188, pALC6486, or pALC6489
for ectopic overexpression of Myc-tagged MazEsa, Axe1, or
Axe2, respectively. Lysates were then made from these strains
either at time points immediately following rifampin treatment
or after 30 min and then analyzed by Western blotting with
-Myc antibodies. As seen in Fig. 3, only lysates from strains
lacking clpC or clpP showed defects in MazEsa, Axe1, and Axe2
degradation after 30 min, suggesting that clpP and clpC were
involved in breakdown of all three S. aureus antitoxins.
clpP, but not clpC, is essential for degradation of all S.
aureus antitoxins. We next examined the overall impact of clpC
and clpP deletions on antitoxin breakdown. To do so, levels of
Myc-tagged MazEsa, Axe1, and Axe2 were followed for almost
2 h in transcriptionally stalled wild-type SH1000 or in isogenic
strains lacking either clpC, clpP, or clpB (as a control). As seen
in Fig. 4E, 5E, and 6E, the levels of all three antitoxins re-
mained unchanged in an SH1000 clpP strain during these 2 h,
while the clpB-complemented (Fig. 4B, 5B, and 6B) and
clpP-complemented (Fig. 4F, 5F, and 6F) strains showed deg-
radation rates similar to those found in wild-type SH1000 (Fig.
4A, 5A, and 6A). A slightly different degradation pattern
emerged when the SH1000 clpC strain was examined. The
MazEsa protein exhibited limited breakdown in the clpC mu-
tant (Fig. 4C) at a rate substantially lower (t1/2 	 46 min) than
in the wild type (t1/2 	 12 min). In contrast, the levels of Axe1
and Axe2 remained steady throughout in the clpC mutant
(Fig. 5C and 6C). In support of our findings, the half-lives of
the respective proteins were restorable to wild-type levels in a
clpC-complemented strain (Fig. 4D, 5D, and 6D). To ensure
that the Myc tag did not alter the profile of proteolysis of the
antitoxin, we replaced the C-terminal Myc tag of Axe2 with an
HA tag. Similar patterns of clpC- and clpP-dependent degra-
dation were seen for these antitoxins with the HA tag and the
Myc tag (Fig. 7). Similar data were obtained with Axe1 (data
FIG. 1. Analysis of protein levels of lysates at different time points from S. aureus strains grown to an A650 of 1.1 and then treated with rifampin
(200 g/ml). (A) Coomassie brilliant blue-stained wild-type SH1000 lysates separated by SDS-PAGE. (B and C) Lysates of wild-type SH1000
lysates separated by SDS-PAGE and immunoblotted using primary antibodies specific for B (B) and SarA (C). (D and E) Immunoblots of lysates
from SH1000 with pALC4077 grown to an A650 of 1.1 with 0.1% xylose and then treated with rifampin (200 g/ml). The immunoblots of these
lysates used primary antibodies specific to MazEsa (D) and MazFsa (E). At the top of each panel is shown the bands from each Western blot, and
the corresponding graph represents the calculation of the original amount of protein detected by densitometry before the addition of rifampin (t	
0). The experiments were repeated three times, and representative blots are shown.
FIG. 2. Axe1 and Axe2 levels in S. aureus SH1000 wild-type cells
following transcriptional arrest with rifampin. Wild-type SH1000 was
transformed with pEPSA5::mazEC-myc (pALC6188), pEPSA5::axe1N-myc
(pALC6486), or pEPSA5::axe2C-myc (pALC6489); grown to an A650 of
1.1 with 0.1% xylose; and then treated with rifampin (200 g/ml).
Samples were taken every 15 min, lysed, and then separated by SDS-
PAGE for immunoblotting with an -Myc primary antibody. The ex-
periments were repeated three times, and representative blots are
displayed.
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not shown). Collectively, these data indicated that clpP was
essential for proteolysis of all three antitoxins in S. aureus,
while clpC was involved in degradation of MazEsa, Axe1, and
Axe2 but was essential for only the last two antitoxins.
DISCUSSION
Maintenance of antitoxin protein levels relies on continued
synthesis in the host bacterium, while any disruption of the
production process causes antitoxin levels to drop, leading to
toxin activation. However, as antitoxin proteolysis has been
described only for E. coli TA systems, our findings that the S.
aureus ATP-dependent protease ClpP and its ATPase chaper-
FIG. 3. Stability of S. aureus antitoxins in SH1000 wild type and strains lacking genes in various ATP-dependent proteolytic pathways. The
wild-type and mutant strains were transformed with pEPSA5::mazEC-myc (pALC6188), pEPSA5::axe1N-myc (pALC6486), or pEPSA5::axe2C-myc
(pALC6489) grown under inducing conditions (0.1% xylose), treated with 200 g/ml rifampin, and harvested either immediately or after 30 min.
Lysates of the samples were subjected to gel electrophoresis and immunoblotting with an -Myc primary antibody. The experiments were repeated
three times, and representative blots are shown.
FIG. 4. Comparative rates of MazEsa degradation in SH1000 wild-
type and clp mutant strains. Wild-type (A), clpB (B), clpC (C), clpC
complemented (D), clpP (E), and clpP complemented (F) strains
were transformed with pEPSA5::mazEC-myc (pALC6188). The cells
were induced and transcriptionally stalled similarly to those in Fig. 3.
At the top of each panel is a Western blot from the respective time
points using a primary -Myc antibody. The graphs depict the percent-
age of signal at each time point compared to t 	 0. The experiments
were repeated three times, and representative blots are shown.
FIG. 5. Comparative rates of Axe1 degradation in SH1000 wild-
type and clp mutant strains. Wild-type (A), clpB (B), clpC (C), clpC
complemented (D), clpP (E), and clpP complemented (F) strains
were transformed with pEPSA5::axe1N-myc (pALC6486). The cells
were treated and analyzed like those in Fig. 4. The experiments were
repeated three times, and representative blots are shown.
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one ClpC function to degrade the antitoxins MazEsa, Axe1,
and Axe2 provide the first evidence that this mechanism of
toxin activation by ClpP is conserved in Gram-positive bacte-
ria, as well. Furthermore, the 12- to 20-min half-lives of the
three S. aureus antitoxins were all considerably shorter than
those of their closest E. coli homologues (MazE, 30 min [1];
YefM, 50 to 60 min [6]). These data suggest that the toxins of
S. aureus TA systems might become activated much more
quickly in response to stimuli than their E. coli counterparts,
which is attributable to the faster decrease in S. aureus anti-
toxins levels.
Interestingly, the genetic components necessary for antitoxin
breakdown were not absolute. While both ClpP and ClpC were
essential for Axe1 and Axe2 degradation, the MazEsa level was
found to decrease in the clpC mutant at one-quarter the rate of
that of the wild type. This finding suggested several possibili-
ties: (i) a second, unannotated chaperone might function to
partially complement ClpC’s breakdown of MazEsa; (ii) an-
other ATP-dependent protease might also process MazEsa;
and (iii) ClpP might still process MazEsa in the absence of
ClpC. The third scenario may be the most likely, as (i) ClpC is
essential for Axe1 and Axe2 degradation, (ii) no other clp-
related gene deletion in our tested mutant strains resulted in a
decreased MazEsa breakdown rate, (iii) deletion of hslV or ftsH
did not alter antitoxin breakdown, and (iv) ClpP may be capa-
ble of slowly degrading proteins independently of an ATPase
chaperone (22).
During our study of Axe1 and Axe2, two antitoxins with 48%
amino acid similarity, we observed that the addition of either a
Myc or an HA epitope tag to the N terminus of Axe2 could
block its degradation, while a similar inhibitory pattern in Axe1
could be obtained only when these tags were added to its C
terminus (data not shown). In silico analyses of these fusions
suggested that the epitope tags did not alter the antitoxins’
secondary structure, nor did they mask any motif known to be
involved in Clp-specific degradation (e.g., LCN, FMLYPK, or
AA motifs from B. subtilis) (8, 36, 38). We are currently inves-
tigating the basis of this proteolytic disparity.
As many TA systems do not have obvious phenotypes, iden-
tification of ClpPC as the functional protease in S. aureus
antitoxin degradation may increase our understanding of the
contributions of TA systems in this and other Gram-positive
organisms. Previously, it was shown that the transcription of
clpC and all three of S. aureus’s TA systems was found to be
increased upon heat shock (5, 12); the subsequent increase in
ClpC levels may enhance toxin activity by virtue of increased
capacity for antitoxin degradation. Furthermore, Chatterjee et
al. (5) showed that a clpC mutant strain survived better over
5 days of growth than the wild type, while a sigB mutant grew
poorly in comparison. In light of our data, a portion of this
increased survival of a clpC strain may be due to the perma-
nent inactivation of toxins that would result from the lack of
antitoxin proteolysis. A similar phenotype may also be found in
a strain lacking all its TA systems, as it would lack the restraints
upon growth that TA systems seem to contribute. The sigB
growth phenotype may be due in part to the derepression of
TA transcription that occurs in a sigB strain (12). Such an
FIG. 6. Comparative rates of Axe2 degradation in SH1000 wild-
type and clp mutant strains. Wild-type (A), clpB (B), clpC (C), clpC
complemented (D), clpP (E), and clpP complemented (F) strains
were transformed with pEPSA5::axe2C-myc (pALC6489). The cells
were treated and analyzed like those in Fig. 4. The experiments were
repeated three times, and representative blots are shown.
FIG. 7. Comparative rates of Axe2 degradation in SH1000 wild-
type and clp mutant strains with an alternate HA epitope tag. Wild-
type (A), clpB (B), clpC (C), and clpP (D) strains were trans-
formed with pEPSA5::axe2C-HA (pALC6682). At the top of each panel
is a Western blot from the respective time points using a primary -HA
antibody. The graphs depict the percentage of signal at each time point
compared to t 	 0. The cells were analyzed like those in Fig. 4. The
experiments were repeated twice, and representative blots are shown.
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increase would lead to the accumulation of stable toxins, which
would necessitate an ever-increasing level of antitoxins. Such a
demand would likely be unsustainable and result in toxin ac-
tivation and, ultimately, decreased survival and/or slower
growth.
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